NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites
NCI 社区肿瘤学研究计划 (NCORP) 少数族裔/服务不足的社区站点
基本信息
- 批准号:10678911
- 负责人:
- 金额:$ 158.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-09 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAddressAdolescentAdvisory CommitteesAftercareAmerican IndiansAsianAwardAwarenessBlack raceCancer BurdenCancer CenterCancer Center Support GrantCancer ControlCancer PatientCancer Therapy Evaluation ProgramCatchment AreaChildhoodClinicalClinical TrialsClinical Trials Cooperative GroupClinical Trials NetworkCollaborationsCommunitiesCommunity Clinical Oncology ProgramCommunity HealthCommunity Health SystemsComprehensive Cancer CenterCountyDisparateDisparityEffectivenessEnrollmentEthnic PopulationFoundationsGenomicsGeographyGoalsGrantGrowthHealthHealth InsuranceHealth PersonnelHealth systemHispanicHispanic PopulationsHospitalsImageIncomeInfrastructureInterventionJointsKnowledgeLeadershipLongevityMalignant NeoplasmsMexicanMinorityMinority GroupsMissionModelingMolecularNational Clinical Trials NetworkNew MexicoNot Hispanic or LatinoPatient-Focused OutcomesPatientsPatternPhysiciansPopulationPopulation HeterogeneityPopulation SciencesPovertyPreventionProviderResearchResearch MethodologyRuralRural CommunityRural PopulationScientistScreening for cancerSiteStrategic PlanningSystemTherapeuticTherapeutic Clinical TrialTherapeutic InterventionTherapeutic TrialsTribesUnderserved PopulationUniversitiesWorkaccess disparitiesbarrier to carebasecancer carecancer clinical trialcancer health disparitycancer preventioncare deliverycare outcomescare providerscommunity based participatory researchcommunity partnershipcommunity settingdata resourceethnic minoritygender minorityhealth disparityimprovedinnovationinterestmembermulti-ethnicnext generationoutcome disparitiesoutreach programparticipant enrollmentpatient orientedprevention clinical trialpreventive interventionprogramsscreeningsuccesstissue resourcetribal Nationunderserved communityunderserved minorityvirtualworking groupyoung adult
项目摘要
PROJECT SUMMARY/ABSTRACT
The overarching goal of the New Mexico MU-NCORP is to improve the quality of cancer care throughout our
catchment area (the State of New Mexico) and to eliminate the tremendous burden of cancer health disparities
in the multiethnic populations that we serve by building innovative statewide outreach programs, founded in
community-based participatory research methods and scientific collaborations between community health
systems and providers with the primary academic affiliate site, resulting in an increased awareness, acceptance,
access, and participation by all New Mexicans in NCI-sponsored cancer screening, post-treatment surveillance,
prevention, and therapeutic clinical trials. The University of New Mexico Comprehensive Cancer (UNMCCC)
serves as the primary affiliate with strong scientific programs in cancer population sciences, cancer control,
health disparities, and clinical interventions, in partnership with nearly all New Mexico health systems and
community cancer care sites that are consortium members of the New Mexico Cancer Care Alliance (NMCCA,
secondary affiliate), a joint 501c3 statewide clinical trials research network that provides the major clinical trials
infrastructure to support the goals of the NCI NCORP. This NM MU-NCORP organization continues to engage
all stakeholders in our cancer health mission and builds upon a well-established 20 year partnership supported
in part by prior NCI MB-CCOP and current NCORP grants. This consortium has a proven track record and
success in enrolling New Mexico's highly diverse multiethnic, rural, and underserved cancer patients in NCTN
trials and has launched several cancer care delivery (CCDR) trials that are of great interest to our community
partners. The NM MU-NCORP will continue to be actively engaged in developing research strategies across the
NCORP Research Bases and will serve as working partners throughout the NCORP Network. With the highest
percentage of Hispanics and American Indians of any state, New Mexico's 2.1 million citizens are 39% non-
Hispanic White, 47% Hispanic, 10% American Indian, 2.4% Black, and 1.6% Asian and other ethnic minorities.
New Mexico ranks at the bottom (48th) in the U.S. in annual per capita income and a substantial number of New
Mexicans, particularly its minority populations, are poor, rural, and underserved. With the nation's highest rate
(30%) of childhood poverty, nearly 20% of all New Mexicans live in poverty and 10-13% of New Mexicans,
depending on the county, still lack health insurance. Our research strategy is focused on academic/community
team partnerships to address all aspects of cancer screening, prevention, cancer control, cancer care delivery,
and therapeutic intervention in order to prioritize and optimize trial-based cancer care, while enhancing
collaboration with the NCORP Research Bases in order to generate the next generation of trials to address the
cancer disparities of the New Mexicans served by the MU-NCORP.
项目概要/摘要
新墨西哥州 MU-NCORP 的总体目标是提高整个州的癌症护理质量
流域(新墨西哥州)并消除癌症健康差异的巨大负担
我们通过建立创新的全州范围外展计划来服务多民族人口,该计划成立于
基于社区的参与性研究方法和社区卫生部门之间的科学合作
系统和提供商与主要学术附属网站的联系,从而提高认识、接受度、
所有新墨西哥人获得并参与 NCI 资助的癌症筛查、治疗后监测、
预防和治疗性临床试验。新墨西哥大学综合癌症中心 (UNMCCC)
作为癌症人口科学、癌症控制、
与几乎所有新墨西哥州卫生系统和机构合作,解决健康差异和临床干预措施
社区癌症护理站点是新墨西哥州癌症护理联盟 (NMCCA,
二级附属机构),一个联合 501c3 全州临床试验研究网络,提供主要的临床试验
支持 NCI NCORP 目标的基础设施。这个 NM MU-NCORP 组织继续参与
我们的癌症健康使命的所有利益相关者,并以建立的 20 年伙伴关系为基础,提供支持
部分由之前的 NCI MB-CCOP 和当前的 NCORP 拨款提供。该财团拥有良好的业绩记录
成功将新墨西哥州高度多样化的多种族、农村和服务不足的癌症患者纳入 NCTN
试验并启动了多项我们社区非常感兴趣的癌症护理服务 (CCDR) 试验
合作伙伴。 NM MU-NCORP 将继续积极参与制定跨领域的研究战略
NCORP 研究基地并将作为整个 NCORP 网络的工作合作伙伴。与最高
各州西班牙裔和美洲印第安人的比例,新墨西哥州 210 万公民中有 39% 是非裔
西班牙裔白人、47% 西班牙裔、10% 美洲印第安人、2.4% 黑人、1.6% 亚裔和其他少数族裔。
新墨西哥州的人均年收入在美国排名垫底(第 48 位),并且有大量新墨西哥人
墨西哥人,尤其是少数族裔,生活贫困,生活在农村,服务水平低下。拥有全国最高的比率
(30%) 儿童贫困,近 20% 的新墨西哥人生活在贫困中,10-13% 的新墨西哥人生活在贫困中,
取决于县,仍然缺乏健康保险。我们的研究策略侧重于学术/社区
团队合作,解决癌症筛查、预防、癌症控制、癌症护理服务的各个方面,
和治疗干预,以便优先考虑和优化基于试验的癌症护理,同时加强
与 NCORP 研究基地合作,以开展下一代试验来解决
MU-NCORP 服务的新墨西哥人的癌症差异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CAROLYN Y MULLER其他文献
CAROLYN Y MULLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CAROLYN Y MULLER', 18)}}的其他基金
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites
NCI 社区肿瘤学研究计划 (NCORP) 少数族裔/服务不足的社区站点
- 批准号:
10227003 - 财政年份:2014
- 资助金额:
$ 158.82万 - 项目类别:
NCI Community Oncology Research Program Minority Underserved Community Sites
NCI 社区肿瘤学研究计划少数群体服务不足的社区站点
- 批准号:
8900255 - 财政年份:2014
- 资助金额:
$ 158.82万 - 项目类别:
Phase I Trial of Intraperitoneal Adenoviral p53 Gene Therapy in Ovarian Cancer
腹腔内腺病毒 p53 基因治疗卵巢癌的 I 期试验
- 批准号:
6975048 - 财政年份:2004
- 资助金额:
$ 158.82万 - 项目类别:
PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER
I期试验腹腔内腺病毒P53基因治疗——卵巢癌
- 批准号:
6567625 - 财政年份:2001
- 资助金额:
$ 158.82万 - 项目类别:
PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER
I期试验腹腔内腺病毒P53基因治疗——卵巢癌
- 批准号:
6414473 - 财政年份:2000
- 资助金额:
$ 158.82万 - 项目类别:
PHASE I TRIAL INTRAPERITONEAL ADENOVIRAL P53 GENE THERAPY--OVARIAN CANCER
I期试验腹腔内腺病毒P53基因治疗——卵巢癌
- 批准号:
6265031 - 财政年份:1998
- 资助金额:
$ 158.82万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Leveraging artificial intelligence methods and electronic health records for pediatric pharmacovigilance
利用人工智能方法和电子健康记录进行儿科药物警戒
- 批准号:
10750074 - 财政年份:2023
- 资助金额:
$ 158.82万 - 项目类别:
Development of Foundational Collaborations and Capabilities to Advance Exposome Research in Childhood-onset Rheumatic Diseases and other Pediatric Autoimmune Conditions
发展基础合作和能力,推进儿童期风湿病和其他儿童自身免疫性疾病的暴露组研究
- 批准号:
10868992 - 财政年份:2023
- 资助金额:
$ 158.82万 - 项目类别:
Predicting Psychiatric Readmission with Machine Learning in Children and Adolescents
通过机器学习预测儿童和青少年的精神病再入院
- 批准号:
10710526 - 财政年份:2022
- 资助金额:
$ 158.82万 - 项目类别:
The Hektoen Institute of Medical Research Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
Hektoen 医学研究所站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709606 - 财政年份:2022
- 资助金额:
$ 158.82万 - 项目类别:
Predicting Psychiatric Readmission with Machine Learning in Children and Adolescents
通过机器学习预测儿童和青少年的精神病再入院
- 批准号:
10604849 - 财政年份:2022
- 资助金额:
$ 158.82万 - 项目类别: